H. Scherubl

Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses.

V. Mazzaferro, J. Bruix, M. Sherman, 2012, Journal of hepatology.

Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer.

D. Schuppan, A. Huether, Viola Baradari, 2006, World journal of gastroenterology.

Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.

B. Wiedenmann, E. Riecken, B. Hamm, 1994, Seminars in oncology.

Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer.

A. Huether, Viola Baradari, A. Sutter, 2006, World journal of gastroenterology.

Targeted medical therapy of biliary tract cancer: recent advances and future perspectives.

D. Schuppan, H. Scherubl, M. Hopfner, 2008, World journal of gastroenterology.

Erythropoetin (epoetin beta) once weekly in anemic patients with advanced cancer of the stomach or gastroesophageal junction: Interim results of a randomized German AIO phase II trail

T. Seufferlein, P. Galle, J. Raedle, 2007 .

Survivin--an anti-apoptosis protein.

H. Scherubl, P. Grabowski, 2003, Medical Science Monitor.